Search results
Australian project to 'print' a fix for faulty eye and brain cells
Cosmos· 1 week ago“Imagine a world that we could simply ‘print’ neurological diseases out of existence using bio inks and cheap desktop printers.” Well ...
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoEnrollment in ACCORD-2 is very far along, and we expect enrollment completion around midyear, With...
Red light therapy for repairing spinal cord injury passes milestone
Medical Xpress· 2 days agoThe method, invented by scientists at the University of Birmingham, U.K. and patented by University...
Model Medicines Appoints Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor
FOX 59 Indianapolis· 2 weeks agoModel Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the appointment of Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor ...
neuroClues wants to put high-speed eye-tracking tech in the doctor's office
TechCrunch· 1 week agoThe eyes aren't just a window into the soul; tracking saccades can help doctors pick up a range of...
Are video game addiction lawsuits having a moment?
Polygon Games· 2 weeks agoLawyers and parents are taking on the video game industry. There are eight lawsuits currently active in North America that seek to address video game...
3 Pharma Stocks With the Potential to Make You an Overnight Millionaire
InvestorPlace via Yahoo Finance· 1 week agoPharmaceutical corporations have long been significant drivers in improving and impacting modern...
Bionxt Solutions Announces Odf Cladribine Update and Financing - BioNxt Solns (OTC:BNXTF)
Benzinga· 2 weeks agoThe Company is reviewing proposals from several contract research organizations to carry out the studies in accordance with EU medical regulatory guidelines. The recent success of both the Company's ...
Q1 2024 KORU Medical Systems Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoThe oncology collaboration is exciting for many reasons. First, the oncology patent therapy patient population is large with up to 500,000 patients as an addressable population ...
NovAccess Global Announces New License to Advance its Immunotherapy Platform
Digital Journal· 1 week agoCLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous ...
